Evidence map›Paper›PMID 40032952›Full record

ArticleNature reviews. Rheumatology2025

Publisher Correction: An international perspective on the future of systemic sclerosis research.

David J Abraham, Carol M Black, Christopher P Denton, Jörg H W Distler, Robyn Domsic, Carol Feghali-Bostwick, Pravitt Gourh, Monique Hinchcliff, Fred Kolling, Masataka Kuwana and 16 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Nature reviews. Rheumatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

26 authors.

David J AbrahamDepartment of Inflammation and Rare Diseases, UCL Centre for Rheumatology, UCL Division of Medicine, Royal Free Hospital Campus, London, UK. david.abraham@ucl.ac.uk.ORCID http://orcid.org/0000-0001-8952-6057
Carol M BlackDepartment of Inflammation and Rare Diseases, UCL Centre for Rheumatology, UCL Division of Medicine, Royal Free Hospital Campus, London, UK.
Christopher P DentonDepartment of Inflammation and Rare Diseases, UCL Centre for Rheumatology, UCL Division of Medicine, Royal Free Hospital Campus, London, UK.ORCID http://orcid.org/0000-0003-3975-8938
Jörg H W DistlerDepartment of Rheumatology, University Hospital Düsseldorf, Medical Faculty of the Heinrich-Heine University, Düsseldorf, Germany.
Robyn DomsicDivision of Rheumatology, Department of Internal Medicine, University of Pittsburgh, Pittsburgh, PA, USA.ORCID http://orcid.org/0000-0002-2765-0922
Carol Feghali-BostwickDepartment of Medicine, Division of Rheumatology and Immunology, Medical University of South Carolina, Charleston, SC, USA.ORCID http://orcid.org/0000-0002-6750-6407
Pravitt GourhScleroderma Genomics and Health Disparities Unit, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, USA.
Monique HinchcliffDivision of Rheumatology, Allergy and Immunology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.ORCID http://orcid.org/0000-0002-8652-9890
Fred KollingGeisel School of Medicine at Dartmouth, Hanover, NH, USA.
Masataka KuwanaDepartment of Allergy and Rheumatology. Nippon Medical School Graduate School of Medicine, Tokyo, Japan.ORCID http://orcid.org/0000-0001-8352-6136
Robert LafyatisDivision of Rheumatology and Clinical Immunology. University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.ORCID http://orcid.org/0000-0002-9398-5034
Ulf LandegrenDepartment of Immunology, Genetics and Pathology, Research programme: Molecular Tools and Functional Genomics, Uppsala University, Uppsala, Sweden.
J Matthew MahoneyThe Jackson Laboratory, Bar Harbour, ME, USA.
Javier MartinDepartment of Cell Biology and Immunology, Institute of Parasitology and Biomedicine López-Neyra, CSIC, Granada, Spain.
Marco Matucci-CerinicUnit of Immunology, Rheumatology, Allergy and Rare Diseases and Inflammation, fibrosis and aging Initiative, IRCCS Ospedle San Raffaele and Vita Salute University San Raffaele, Milan, Italy.
Zsuzsanna H McMahanDepartment of Internal Medicine, Division of Rheumatology, UTHealth Houston, Houston, TX, USA.
Ana L MoraDivision of Pulmonary, Critical Care and Sleep Medicine, Davis Heart and Lung research Institute, The Ohio State University College of Medicine, Columbus, OH, USA.
Luc MouthonDepartment of Internal Medicine, Reference Center for Rare Systemic Autoimmune and Auto-Inflammatory diseases in Île-de-France, East and West, Cochin Hospital, Public Assistance-Hospitals of Paris, Paris-Centre, Paris Cité University, Paris, France.
Marlene RabinovitchDepartment of Paediatrics, Stanford University School of Medicine, Stanford, CA, USA.
Mauricio RojasDivision of Pulmonary, Critical Care and Sleep Medicine, Davis Heart and Lung research Institute, The Ohio State University College of Medicine, Columbus, OH, USA.
Kristofer RubinDepartment of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.
Maria TrojanowskaBoston University, Department of Medicine, Arthritis & Autoimmune Diseases Research Center, Boston, MA, USA.ORCID http://orcid.org/0000-0001-9550-7178
John VargaDivision of Rheumatology, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, USA.
Michael L WhitfieldDepartment of Biomedical Data Science, Department of Molecular and Systems Biology, Geisel School of Medicine at Dartmouth, Hanover, NH, USA.ORCID http://orcid.org/0000-0002-0862-6003
Armando GabrielliHiller Research Center, University Hospital Düsseldorf, Medical Faculty of Heinrich Heine University, Düsseldorf, Germany. a.gabrielli@staff.univpm.it.ORCID http://orcid.org/0000-0003-3189-5516
Thomas KriegTranslational Matrix Biology, Cologne Excellence Cluster on Cellular Stress Responses in Ageing-Associated Diseases (CECAD) and Center for Molecular Medicine (CMMC) University of Cologne, Cologne, Germany. thomas.krieg@uni-koeln.de.ORCID http://orcid.org/0000-0001-5616-8476

Funding

Validating Novel Outcomes to Enable Systemic Sclerosis Calcinosis Cutis Clinical TrialsR01AR085316 · NIAMS · YALE UNIVERSITY · PI MONIQUE Evangeline HINCHCLIFF · 2025 to 2026
$487k
NIAMS NIH HHS R01 AR085316
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40032952

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.